IGM Biosciences Inc (IGMS)
9.18
-0.11
(-1.18%)
USD |
NASDAQ |
May 17, 16:00
9.18
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Price to Book Value: 3.375 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 3.375 |
| May 16, 2024 | 3.400 |
| May 15, 2024 | 3.474 |
| May 14, 2024 | 3.368 |
| May 13, 2024 | 3.393 |
| May 10, 2024 | 3.419 |
| May 09, 2024 | 3.704 |
| May 08, 2024 | 3.419 |
| May 07, 2024 | 3.635 |
| May 06, 2024 | 3.671 |
| May 03, 2024 | 3.686 |
| May 02, 2024 | 3.452 |
| May 01, 2024 | 3.47 |
| April 30, 2024 | 3.521 |
| April 29, 2024 | 3.546 |
| April 26, 2024 | 3.437 |
| April 25, 2024 | 2.797 |
| April 24, 2024 | 2.910 |
| April 23, 2024 | 2.815 |
| April 22, 2024 | 2.468 |
| April 19, 2024 | 2.632 |
| April 18, 2024 | 2.709 |
| April 17, 2024 | 2.972 |
| April 16, 2024 | 3.364 |
| April 15, 2024 | 3.440 |
| Date | Value |
|---|---|
| April 12, 2024 | 3.349 |
| April 11, 2024 | 3.056 |
| April 10, 2024 | 2.990 |
| April 09, 2024 | 3.195 |
| April 08, 2024 | 3.202 |
| April 05, 2024 | 3.202 |
| April 04, 2024 | 3.25 |
| April 03, 2024 | 3.301 |
| April 02, 2024 | 3.341 |
| April 01, 2024 | 3.455 |
| March 31, 2024 | |
| March 28, 2024 | 2.791 |
| March 27, 2024 | 2.681 |
| March 26, 2024 | 2.511 |
| March 25, 2024 | 2.519 |
| March 22, 2024 | 2.976 |
| March 21, 2024 | 2.959 |
| March 20, 2024 | 2.852 |
| March 19, 2024 | 2.869 |
| March 18, 2024 | 3.020 |
| March 15, 2024 | 3.078 |
| March 14, 2024 | 2.950 |
| March 13, 2024 | 2.878 |
| March 12, 2024 | 2.878 |
| March 11, 2024 | 3.023 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9062
Minimum
Oct 31 2023
18.77
Maximum
Dec 08 2020
4.847
Average
3.532
Median
Feb 07 2023
Price to Book Value Benchmarks
| Akoya Biosciences Inc | 4.301 |
| Xilio Therapeutics Inc | 1.633 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
| iBio Inc | 0.7501 |
Price to Book Value Related Metrics
| PS Ratio | 246.08 |
| Price | 9.18 |
| Earnings Yield | -46.42% |
| Market Cap | 544.20M |